Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments

This publication has 25 references indexed in Scilit:

• Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors
  Nature Biotechnology, 2004
• Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion
  Nuclear Medicine and Biology, 2004
• Labeling anti-HER2/neu Monoclonal Antibodies with ¹¹¹In and ⁹⁰Y Using a Bifunctional DTPA Chelating Agent
  Cancer Biotherapy & Radiopharmaceuticals, 2003
• A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™
  Nuclear Medicine and Biology, 2002
• Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer
  British Journal of Surgery, 2002
• Trastuzumab and Breast Cancer
  New England Journal of Medicine, 2001
• Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry
  Journal of Clinical Oncology, 2000
• Problems of Delivery of Monoclonal Antibodies
  Clinical Pharmacokinetics, 1995
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
  Nature, 1984